OBX · Obsidian Therapeutics, Inc. · Insider Trading

$13.93 +0.68 (+5.13%)

Market Cap

$818.49M

61.77M

Volume · Oct 21 332.85K Avg daily vol (3M) 381.13K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-08-03	Jagasia Madan	Director, Chief Executive Officer	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653
2026-08-03	Fardis Maria	Director, President and CEO	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653
2026-08-03	Hagen Heidi	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653
2026-08-03	Norkunas Matthew	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653
2026-08-03	Barrett Peter	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653
2026-08-03	ROSS ROBERT W.	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The shares underlying this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Issuer's annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.	Stock Option (Right to Buy)	37,653	—	—	37,653

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–6 of 6 transactions

Key facts CIK 2130606 CUSIP 67448A106 Visit website Investor relations